These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7677269)

  • 1. Vaccines released.
    Am J Infect Control; 1995 Jun; 23(3):213. PubMed ID: 7677269
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccination against hepatitis A].
    Germanaud J; Causse X
    Servir; 1994; 42(3):161-4. PubMed ID: 8059246
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivated candidate vaccines for hepatitis A.
    André FE; Hepburn A; D'Hondt E
    Prog Med Virol; 1990; 37():72-95. PubMed ID: 2173850
    [No Abstract]   [Full Text] [Related]  

  • 4. Licensed preparations against hepatitis A and chickenpox: vaccine update--Part 2.
    Molinari JA; Merchant VA
    Compend Contin Educ Dent; 1996 Jun; 17(6):520-4, 526. PubMed ID: 9051961
    [No Abstract]   [Full Text] [Related]  

  • 5. Release potency tests of hepatitis vaccines.
    Descamps J; Mary A; Rommel E; Anhoury ML; De Neys R; Duchêne M
    Dev Biol Stand; 1999; 101():289-94. PubMed ID: 10566803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated virosome hepatitis A vaccine.
    D'Hondt E; Delem A
    Lancet; 1994 May; 343(8906):1165-6. PubMed ID: 7910259
    [No Abstract]   [Full Text] [Related]  

  • 7. Licensure of Varicella Virus Vaccine, Live.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Apr; 44(13):264. PubMed ID: 7898423
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 9. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine.
    Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
    Isr J Med Sci; 1994; 30(5-6):485-8. PubMed ID: 8034508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.
    Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A
    Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vacillate or vaccinate.
    Bednarsh H
    Dent Assist; 1995 Oct; 64(4):6-7. PubMed ID: 9525123
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistence of antibodies after inactivated hepatitis A vaccines in a comparative study.
    Goilav C; Zuckerman J; Lafrenz M; Vidor E; Briantais P; Lauwers S; Ratheau C; Benichou G; Zuckerman A
    J Infect; 1997 Mar; 34(2):158. PubMed ID: 9138144
    [No Abstract]   [Full Text] [Related]  

  • 13. Administration of varicella vaccine to children with leukemia.
    Brunell PA; Taylor-Wiedeman J; Shehab ZM; Geiser C; Frierson LS; Cobb EK
    Biken J; 1984 Sep; 27(2-3):83-8. PubMed ID: 6100064
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
    Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ
    Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of live attenuated varicella vaccine.
    Gershon AA
    Proc Assoc Am Physicians; 1995 Oct; 107(3):365-8. PubMed ID: 8608424
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis A inoculation].
    Jilg W
    Dtsch Med Wochenschr; 1994 Dec; 119(51-52):1800. PubMed ID: 7736937
    [No Abstract]   [Full Text] [Related]  

  • 17. New picornavirus vaccines for hepatitis A, and lessons from the control of poliomyelitis by the prototype picornavirus vaccines.
    Melnick JL
    Prog Med Virol; 1990; 37():47-55. PubMed ID: 2173848
    [No Abstract]   [Full Text] [Related]  

  • 18. A redoubtable obstacle to a hepatitis C vaccine.
    Koff RS
    Gastroenterology; 1993 Apr; 104(4):1228-9. PubMed ID: 8385045
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vaccines: from seed virus to approval].
    Bruhn C
    Dtsch Med Wochenschr; 2009 Nov; 134(48):p44. PubMed ID: 19941270
    [No Abstract]   [Full Text] [Related]  

  • 20. AAP develops guidelines for hepatitis A vaccine and immune globulin in children. American Academy of Pediatrics.
    Am Fam Physician; 1997 May; 55(7):2535-6. PubMed ID: 9166149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.